JL Steegmann, J Odriozola, F Rodriguez-Salvanes, P Giraldo, J Garcia-Larana, MT Ferro, E Benitez, C Perez-Pons, M Giralt, L Escribano, E Lavilla, A Miguel, C Areal, M Perez-Encinas, A Abad, J Maldonado, I Massague, JM Fernandez-Ranada. Stage, percentage of basophils at diagnosis, hematologic response within six months, cytogenetic response in the first year: the main prognostic variables affecting outcome in patients with chronic myeloid leukemia in chronic phase treated with interferon-alpha. Results of the CML89 trial of the Spanish Collaborative Group on interferon-alpha2a and CML. Haematologica 1999;84(11):978-987; https://doi.org/10.3324/%x.